Clinical Trials Directory

Trials / Completed

CompletedNCT02160717

Risk of Diabetes in Young Turner Syndrome Patients

Beta-Cell Function in Young Turner Syndrome Patients

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
Female
Age
6 Years – 22 Years
Healthy volunteers
Accepted

Summary

Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objective of this study is to determine if there are abnormalities in glucose metabolism and pancreatic function in young girls with Turner Syndrome. The study hypothesis is that pancreatic dysfunction (specifically of the beta cells that make insulin) is more prevalent in girls with Turner Syndrome compared to healthy controls.

Detailed description

The study will be conducted at Children's Hospital Medical Center, Cincinnati. The study will require 1 visit to the hospital where the subject will have an oral glucose tolerance test and a physical exam

Conditions

Timeline

Start date
2014-05-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2014-06-11
Last updated
2017-08-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02160717. Inclusion in this directory is not an endorsement.

Risk of Diabetes in Young Turner Syndrome Patients (NCT02160717) · Clinical Trials Directory